Get the Stockscreener App
41.96
3.71%
1.50
After Hours:
41.96
Quidelortho Corporation stock is traded at $41.96, with a volume of 900.01K.
It is up +3.71% in the last 24 hours and down -5.15% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
See More
Previous Close:
$40.46
Open:
$40.38
24h Volume:
900.01K
Relative Volume:
0.93
Market Cap:
$2.82B
Revenue:
$2.82B
Net Income/Loss:
$-1.87B
P/E Ratio:
-1.5039
EPS:
-27.9
Net Cash Flow:
$-96.80M
1W Performance:
+3.43%
1M Performance:
-5.15%
6M Performance:
-6.78%
1Y Performance:
-10.51%
1-Day Range:
$40.38
$42.06
1-Week Range:
$39.90
$42.50
52-Week Range:
$29.73
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
41.96 | 2.82B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
Inside QuidelOrtho's Growth Strategy: Key Insights Coming at Raymond James Conference - StockTitan
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 – QDEL - ACCESS Newswire
QuidelOrtho Co. (NASDAQ:QDEL) Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders - ACCESS Newswire
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
QuidelOrtho: Growth Struggles And Negative GAAP Earnings Continue To Disinterest Investors - Seeking Alpha
$30+ Bn Primary Care POC Diagnostics Market Opportunities - GlobeNewswire
Why QuidelOrtho Stock Bounced More Than 4% Higher Today - MSN
QDEL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
QuidelOrtho Co. (NASDAQ:QDEL) Sees Significant Decrease in Short Interest - MarketBeat
In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.
January 2026 Options Now Available For QuidelOrtho (QDEL) - Nasdaq
QuidelOrtho Co. (NASDAQ:QDEL) Receives $51.20 Average PT from Analysts - MarketBeat
QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024 - MSN
QuidelOrtho's SWOT analysis: stock poised for growth amid challenges - MSN
Stephens Inc. AR Acquires Shares of 14,915 QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QDEL DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline - ACCESS Newswire
QuidelOrtho (NASDAQ:QDEL) Trading Down 4.9% Following Analyst Downgrade - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Shares Gap Up Following Analyst Upgrade - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Price Target Raised to $45.00 - MarketBeat
18,856 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by Legato Capital Management LLC - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Cut to Hold at StockNews.com - MarketBeat
QuidelOrtho's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
QuidelOrtho (NASDAQ:QDEL) Issues FY 2025 Earnings Guidance - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Issues Quarterly Earnings Results, Misses Estimates By $0.44 EPS - MarketBeat
QuidelOrtho projects $2.6B-$2.81B revenue for 2025 supported by cost savings and margin expansion - MSN
QuidelOrtho (NASDAQ:QDEL) Announces Quarterly Earnings Results - MarketBeat
QuidelOrtho 2025 EPS, revenue guidance ranges include consensus - MSN
QuidelOrtho Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St
Lightrock Netherlands B.V. Takes $10.05 Million Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates - MSN
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2024 Earnings Call Transcript - MSN
Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Bus. Run on... - br.ADVFN.com
QuidelOrtho’s Earnings Call: Mixed Sentiment Amidst Revenue Decline - TipRanks
QDELQuidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics - br.ADVFN.com
Where QuidelOrtho Stands With Analysts - Benzinga
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract - Yahoo Finance
UBS Raises Price Target on QuidelOrtho to $45 From $43, Maintains Neutral Rating - Marketscreener.com
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):